Jenkins George Minsider trades
In SEC Form 4 filings, Jenkins George M is listed as Director of Palvella Therapeutics, Inc. (PVLA). In the last 90 days, Jenkins George M sold $7.75M of Palvella Therapeutics, Inc. (PVLA) on the open market and bought none. All 26 sales were reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| PVLAPalvella Therapeutics, Inc. | Director | 26 | Oct 14 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-15
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| PVLAPalvella Therapeutics, Inc. | Oct 14 | Oct 14 | S | 476 | $121.14 | Sale −$57,663 | 139,314 | Yes | Form 4 |
| PVLAPalvella Therapeutics, Inc. | Oct 14 | Oct 14 | S | 2,072 | $122.62 | Sale −$254,058 | 137,242 | Yes | Form 4 |
| PVLAPalvella Therapeutics, Inc. | Oct 14 | Oct 14 | S | 2,604 | $123.29 | Sale −$321,046 | 134,638 | Yes | Form 4 |
| PVLAPalvella Therapeutics, Inc. | Oct 14 | Oct 14 | S | 920 | $124.37 | Sale −$114,416 | 133,718 | Yes | Form 4 |
| PVLAPalvella Therapeutics, Inc. | Oct 14 | Oct 14 | S | 597 | $125.33 | Sale −$74,820 | 133,121 | Yes | Form 4 |
| PVLAPalvella Therapeutics, Inc. | Oct 14 | Oct 14 | S | 505 | $126.55 | Sale −$63,910 | 132,616 | Yes | Form 4 |
| PVLAPalvella Therapeutics, Inc. | Oct 13 | Oct 14 | S | 2,004 | $128.52 | Sale −$257,555 | 144,960 | Yes | Form 4 |
| PVLAPalvella Therapeutics, Inc. | Oct 13 | Oct 14 | S | 1,644 | $129.23 | Sale −$212,455 | 143,316 | Yes | Form 4 |
| PVLAPalvella Therapeutics, Inc. | Oct 13 | Oct 14 | S | 990 | $130.48 | Sale −$129,175 | 142,326 | Yes | Form 4 |
| PVLAPalvella Therapeutics, Inc. | Oct 13 | Oct 14 | S | 1,035 | $131.49 | Sale −$136,092 | 141,291 | Yes | Form 4 |
| PVLAPalvella Therapeutics, Inc. | Oct 13 | Oct 14 | S | 579 | $132.40 | Sale −$76,662 | 140,712 | Yes | Form 4 |
| PVLAPalvella Therapeutics, Inc. | Oct 13 | Oct 14 | S | 922 | $133.72 | Sale −$123,292 | 139,790 | Yes | Form 4 |
| PVLAPalvella Therapeutics, Inc. | Oct 12 | Oct 14 | S | 5,095 | $132.62 | Sale −$675,681 | 155,021 | Yes | Form 4 |
| PVLAPalvella Therapeutics, Inc. | Oct 12 | Oct 14 | S | 2,458 | $133.25 | Sale −$327,524 | 152,563 | Yes | Form 4 |
| PVLAPalvella Therapeutics, Inc. | Oct 12 | Oct 14 | S | 3,335 | $134.21 | Sale −$447,586 | 149,228 | Yes | Form 4 |
| PVLAPalvella Therapeutics, Inc. | Oct 12 | Oct 14 | S | 1,447 | $135.50 | Sale −$196,064 | 147,781 | Yes | Form 4 |
| PVLAPalvella Therapeutics, Inc. | Oct 12 | Oct 14 | S | 817 | $136.44 | Sale −$111,475 | 146,964 | Yes | Form 4 |
| PVLAPalvella Therapeutics, Inc. | Sep 15 | Sep 15 | S | 954 | $149.38 | Sale −$142,507 | 160,939 | Yes | Form 4 |
| PVLAPalvella Therapeutics, Inc. | Sep 15 | Sep 15 | S | 263 | $150.40 | Sale −$39,556 | 160,676 | Yes | Form 4 |
| PVLAPalvella Therapeutics, Inc. | Sep 15 | Sep 15 | S | 560 | $151.33 | Sale −$84,743 | 160,116 | Yes | Form 4 |
| PVLAPalvella Therapeutics, Inc. | Sep 14 | Sep 15 | S | 5,632 | $151.46 | Sale −$853,037 | 169,613 | Yes | Form 4 |
| PVLAPalvella Therapeutics, Inc. | Sep 14 | Sep 15 | S | 6,160 | $152.12 | Sale −$937,034 | 163,453 | Yes | Form 4 |
| PVLAPalvella Therapeutics, Inc. | Sep 14 | Sep 15 | S | 1,560 | $153.10 | Sale −$238,834 | 161,893 | Yes | Form 4 |
| PVLAPalvella Therapeutics, Inc. | Sep 11 | Sep 15 | S | 6,520 | $150.62 | Sale −$982,035 | 181,096 | Yes | Form 4 |
| PVLAPalvella Therapeutics, Inc. | Sep 11 | Sep 15 | S | 4,577 | $151.72 | Sale −$694,403 | 176,519 | Yes | Form 4 |
| PVLAPalvella Therapeutics, Inc. | Sep 11 | Sep 15 | S | 1,274 | $153.06 | Sale −$194,997 | 175,245 | Yes | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.